Linking triphenylphosphonium cation to a bicyclic hydroquinone improves their antiplatelet effect via the regulation of mitochondrial function
Redox Biology · 2024
DOI: 10.1016/j.redox.2024.103142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Redox Biology, 2024. Verfasst von Diego Méndez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Thrombosis and Healthy Aging Research Center, MIBI: Interdisciplinary Group on Mitochondrial Targeting and Bioenergetics, Medical Technology School, …. Hauptthemen laut MEDLINE: Blood Platelets, Hydroquinones, Membrane Potential, Mitochondrial, Organophosphorus Compounds. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANID.
Abstract (Originalsprache)
Platelets are the critical target for preventing and treating pathological thrombus formation. However, despite current antiplatelet therapy, cardiovascular mortality remains high, and cardiovascular events continue in prescribed patients. In this study, first results were obtained with ortho-carbonyl hydroquinones as antiplatelet agents; we found that linking triphenylphosphonium cation to a bicyclic ortho-carbonyl hydroquinone moiety by a short alkyl chain significantly improved their antiplatelet effect by affecting the mitochondrial functioning. The mechanism of action involves uncoupling OXPHOS, which leads to an increase in mitochondrial ROS production and a decrease in the mitochondrial membrane potential and OCR. This alteration disrupts the energy production by mitochondrial function necessary for the platelet activation process. These effects are responsive to the complete structure of the compounds and not to isolated parts of the compounds tested. The results obtained in this research can be used as the basis for developing new antiplatelet agents that target mitochondria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thrombosis and Healthy Aging Research Center, MIBI: Interdisciplinary Group on Mitochondrial Targeting and Bioenergetics, Medical Technology School, Department of Clinical Biochemistry and Immunohematology, Faculty of H…
- Instituto de Química de Recursos Naturales, MIBI: Interdisciplinary Group on Mitochondrial Targeting and Bioenergetics, Universidad de Talca, Talca, 3460000, Chile.
- Departamento de Métodos Cuantitativos and Centro de Investigaciones Biomédicas (CEINBIO), Facultad de Medicina, Universidad de la República, Montevideo, 11800, Uruguay.
- Departamento de Bioquímica and Centro de Investigaciones Biomédicas (CEINBIO), Facultad de Medicina, Universidad de la República, Montevideo, 11800, Uruguay.
- Centro Avanzado de Enfermedades Crónicas (ACCDiS), Universidad de Chile, Chile.
- Institute of Biochemistry II, Goethe University Medical School, Germany.
Förderung
- ANID
Zitieren
APA
Méndez, D., Tellería, F., Monroy-Cárdenas, M., Montecino-Garrido, H., Mansilla, S., Castro, L., Trostchansky, A., Muñoz-Córdova, F., Zickermann, V., Schiller, J., Alfaro, S., Caballero, J., Araya-Maturana, R., & Fuentes, E. (2024). Linking triphenylphosphonium cation to a bicyclic hydroquinone improves their antiplatelet effect via the regulation of mitochondrial function. Redox Biology. https://doi.org/10.1016/j.redox.2024.103142
Vancouver
Méndez D, Tellería F, Monroy-Cárdenas M, Montecino-Garrido H, Mansilla S, Castro L, et al. Linking triphenylphosphonium cation to a bicyclic hydroquinone improves their antiplatelet effect via the regulation of mitochondrial function. Redox Biology. 2024. doi:10.1016/j.redox.2024.103142
BibTeX
@article{Mndez2024,
author = {Méndez, Diego and Tellería, Francisca and Monroy-Cárdenas, Matías and Montecino-Garrido, Héctor and Mansilla, Santiago and Castro, Laura and Trostchansky, Andrés and Muñoz-Córdova, Felipe and Zickermann, Volker and Schiller, Jonathan and Alfaro, Sergio and Caballero, Julio and Araya-Maturana, Ramiro and Fuentes, Eduardo},
title = {Linking triphenylphosphonium cation to a bicyclic hydroquinone improves their antiplatelet effect via the regulation of mitochondrial function},
journal = {Redox Biology},
year = {2024},
doi = {10.1016/j.redox.2024.103142}
}
EUVIMED